JACC: CardioOncology - Dual Angiotensin Receptor Neprilysin Inhibition with Sacubitril/Valsartan Attenuates Systolic Dysfunction in Experimental Doxorubicin-induced Cardiotoxicity
Episode Description
Commentary by Dr. Virginia Hahn
We use cookies to run this site. Analytics cookies, which show us how it's used, stay off unless you accept them. Change your mind any time with the cookie button at the bottom right. How we use cookies